Blockade of the CD40-CD40 ligand pathway potentiates the capacity of donor-derived dendritic cell progenitors to induce long-term cardiac allograft survival

Transplantation

Volumn 64, Issue 12, 1997, Pages 1808-1815

  Lina, L U ^a   Wei, L I ^a   Fumin, F U ^a   Chambers, Frances G ^a   Qian, Shiguang ^a   Fung, John J ^a   Thomson, Angus W ^a,b  

^a UNIVERSITY OF PITTSBURGH MEDICAL CENTER   (United States)

^b UNIVERSITY OF PITTSBURGH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD40 ANTIGEN; GLYCOPROTEIN GP 39; MONOCLONAL ANTIBODY; MONOCLONAL ANTIBODY CD 40L; TRANSFORMING GROWTH FACTOR BETA RECEPTOR; UNCLASSIFIED DRUG;

ALLOGENEIC RESTRICTION; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; CELL INTERACTION; CONFERENCE PAPER; CONTROLLED STUDY; CYTOTOXIC T LYMPHOCYTE; DENDRITIC CELL; GRAFT SURVIVAL; HEART TRANSPLANTATION; INTRAPERITONEAL DRUG ADMINISTRATION; LIGAND BINDING; MALE; MOUSE; NONHUMAN; ORGAN DONOR; PRIORITY JOURNAL; RECEPTOR BLOCKING; STEM CELL;

ANIMALS; ANTIBODIES, MONOCLONAL; ANTIGENS, CD40; BONE MARROW CELLS; CD40 LIGAND; CYTOTOXICITY, IMMUNOLOGIC; DENDRITIC CELLS; GRAFT REJECTION; GRAFT SURVIVAL; GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR; HEART TRANSPLANTATION; IMMUNOPHENOTYPING; IMMUNOSUPPRESSION; INTERLEUKIN-4; MALE; MEMBRANE GLYCOPROTEINS; MICE; MICE, INBRED BALB C; MICE, INBRED C3H; MICE, INBRED C57BL; SPLEEN; T-LYMPHOCYTES; T-LYMPHOCYTES, CYTOTOXIC; TIME FACTORS; TISSUE DONORS; TRANSFORMING GROWTH FACTOR BETA;

EID: 0344906174     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/00007890-199712270-00031     Document Type: Conference Paper

References (61)

1. Steinman RM. The dendritic cell system and its role in immunogenicity. Annu Rev Immunol 1991; 9: 271.
2. Starzl TE, Demetris AJ, Murase N, Ildstad S, Ricordi C, Trucco M. Cell migration, chimerism, and graft acceptance. Lancet 1992; 339: 1579.
3. Starzl TE, Demetris AJ, Trucco M, et al. Cell migration and chimerism after whole organ transplantation: the basis of graft acceptance. Hepatology 1993; 17: 1127.
4. Knight SC, Hung R, Dorse C, Medawar PB. Influence of dendritic cells on tumor growth. Proc Natl Acad Sci USA 1985; 82: 4495.
5. Clare-Salzler MJ, Brooks J, Chai A, Van Herle K, Anderson C. Prevention of diabetes in nonobese diabetic mice by dendritic cell transfer. J Clin Invest 1992; 90: 741.
6. -) induce alloantigen-specific hyporesponsiveness in murine T lymphocytes. Transplantation 1995; 60: 1539.
7. Thomson AW, Lu L, Murase N, Demetris AJ, Rao AS, Starzl TE. Microchimerism, dendritic cell progenitors and transplantation tolerance. Stem Cells 1995; 13: 622.
8. Khoury SJ, Gallon L, Chen W, et al. Mechanisms of acquired thymic tolerance in experimental autoimmune encephalomyelitis: thymic dendritic-enriched cells induce specific peripheral T cell unresponsiveness in vivo. J Exp Med 1995; 182: 357.
9. Finkelman FD, Lees A, Bimbaum R, Gause WC, Morris SC. Dendritic cells can present antigen in vivo in a tolerogenic or immunogenic fashion. J Immunol 1996; 157: 1406.
10. Grohmann U, Bianchi R, Ayroldi E, et al. A tumor-associated and self antigen peptide presented by dendritic cells may induce T cell anergy in vivo, but IL-12 can prevent or revert the anergic state. J Immunol 1997; 158: 3593.
11. Rastellini C, Lu L, Ricordi C, Starzl TE, Rao AS, Thomson AW. GM-CSF stimulated hepatic dendritic cell progenitors prolong pancreatic islet allograft survival. Transplantation 1995; 60: 1366.
12. -) prolong cardiac allograft survival in non-immunosuppressed recipients. Transplantation 1996; 62: 649.
13. + T helper cells. J Immunol 1991; 146: 485.
14. Enk AH, Angeloni VL, Udey MC, Katz SI. Inhibition of Langerhans cell antigen-presenting function by IL-10: A role for IL-10 in induction of tolerance. J Immunol 1993; 151: 2390.
15. Demiden A, Taylor JR, Grammer S, et al. Comparison of effects of transforming growth factor-β and cyclosporin A on antigen-presenting cells of blood and epidermis. J Invest Dermatol 1991; 96: 401.
16. Khoury SJ, Gallon L, Verburg RR, et al. Ex vivo treatment of antigen-presenting cells with CTLA4Ig and encephalitogenic peptide prevents experimental autoimmune encephalomyelitis in the Lewis rat. J Immunol 1996; 157: 3700.
17. Austyn JM. The initiation of immune responses and allograft rejection. In: Rose ML, Yacoub MH, eds. Immunology of heart and lung transplantation. Boston: Little, Brown & Co., Ltd., 1993: 22.
18. Steinman RM, Inaba K, Austyn JM. Donor-derived chimerism in recipients of organ transplants. Hepatology 1993; 17: 1153.
19. Lu L, Woo J, Rao AS, Li Y, et al. Propagation of dendritic cell progenitors from normal mouse liver using GM-CSF and their maturational development in the presence of type-1 collagen. J Exp Med 1994; 179: 1823.
20. Jenkins MK, Johnson JG. Molecules involved in T-cell costimulation. Curr Opin Immunol 1993; 5: 361.
21. June CH, Bluestone JA, Nadler M, Thompson CB. B71/2: T cell costimulation. Immunol Today 1994; 15: 321.
22. Kennedy MK, Mohler KM, Shanebeck KD et al. Induction of B cell costimulatory function by recombinant murine CD40 ligand. Eur J Immunol 1994; 24: 116.
23. Grewal IS, Flavell RA. The role of CD40 ligand in immunity and auto-immunity. In Immune Tolerance. Banchereau J, Dodet B, Schwartz R, Trannoy E (eds), Elsevier. Paris; 1996; pp. 125-133
24. Durie FH, Foy TM, Masters SR, Laman JD, Noelle RJ. The role of CD40 in the regulation of humoral and cell-mediated immunity. Immunol Today 1994; 15: 406.
25. Xu J, Foy TM, Laman JD et al. Mice deficient for the CD40 ligand. Immunity 1994; 1: 423.
26. Renshaw BR, Fanslow WC, Armitage RJ et al. Humoral immune responses in CD40 ligand-deficient mice. J Exp Med 1994; 180: 1889.
27. Yamaguchi Y, Tsumura H, Miwa M, Inaba K. Contrasting effects of TGF-β1 and TNF-α on the development of dendritic cells from progenitors in mouse bone marrow. Stem Cells 1997; 15: 144.
28. Riedl E, Strobl H, Majdic O, Knapp W. TGF-β1 promotes in vitro generation of dendritic cells by protecting progenitor cells from apoptosis. J Immunol 1997; 158: 1591.
29. Inaba K, Inaba M, Romani N, et al. Generation of large numbers of dendritic cells from mouse bone marrow cultures supplemented with granulocyte/macrophage colony-stimulating factor. J Exp Med 1992; 176: 1693.
30. Lu L, Bonham CA, Chambers FG, Watkins SC, Hoffman RA, Simmons RL, Thomson AW. Induction of nitric oxide synthase in mouse dendritic cells by interferon γ, endotoxin and interaction with allogeneic T cells: nitric oxide production is associated with dendritic cell apoptosis. J Immunol 1996 157: 3577.
31. Qian S, Demetris AJ, Murase N, Rao AS, Fung JJ, Starzl TE. Murine liver allograft transplantation: tolerance and donor cell chimerism. Hepatology 1994; 19: 916.
32. Fuchs EJ, Matzinger P. B cells turn off virgin but not memory T cells. Science 1992; 258: 1156.
33. Derynck R. Transforming growth factor-β. In: Thomson AW, ed. The cytokine handbook, 2nd ed. San Diego: Academic Press, 1994; 319.
34. Hooper WC, Pruckler J, Jackson D et al. The synergistic effect of hemin and transforming growth factor-β on hemoglobin accumulation in HEL erythroleukemia cells. Leuk Res 1991; 15: 753.
35. Keller JR, Jacobsen SEW, Sill K, et al. Stimulation of granulopoiesis by transforming growth factor β: synergy with granulocyte/macrophage-colony-stimulating factor. Proc Natl Acad Sci USA 1991; 88: 7190.
36. Gruschwitz MS, Hornstein OP. Expression of transforming growth factor type β on human epidermal dendritic cells. J Invest Dermatol 1992; 99: 114.
37. Bonham CA, Lu L, Banas RA, et al. TGF-β1 pretreatment impairs the allostimulatory function of human bone marrow-derived antigen-presenting cells for both naive and primed T cells. Transplant Immunol 1996; 4: 186.
38. Raju GP, Belland SE, Eisen HJ. Prolongation of cardiac allograft survival with transforming growth factor-β1 in rats. Transplantation 1994; 58: 392.
39. Wilbanks GA, Streilein JW. Fluids from immune privileged sites endow macrophages with the capacity to induce antigen-specific immune deviation via a mechanism involving transforming growth factor-β. Eur J Immunol 1992; 22: 1031.
40. Verbanac KM, Carver FM, Haisch CE, Thomas JM. A role for transforming growth factor-β in the veto mechanism in transplant tolerance. Transplantation 1994; 57: 893.
41. Thomas JM, Carver FM, Kasten-Jolly, J, et al. Further studies of veto activity in rhesus monkey bone marrow in relation to allograft tolerance and chimerism. Transplantation 1994; 57: 101.
42. Czarniecki CW, Chiu HH, Wong GH, McCabe SM, Palladino MA. Transforming growth factor-β 1 modulates the expression of class II histocompatibility antigens on human cells. J Immunol 1988; 140: 4217.
43. Armitage RJ, Fanslow WC, Strockbine L, et al. Molecular and biological characterization of a murine ligand for CD40. Nature 1992; 357: 80.
44. Foy TM, Aruffo A, Ledbetter JA, Noelle RJ. In vivo CD40-gp39 interactions are essential for thymus-dependent immunity. II. Prolonged in vivo suppression of primary and secondary humoral immune responses by an antibody targeted to the CD40 ligand, gp39. J Exp Med 1993; 178: 1567.
45. Yang Y, Wilson JM. CD40 ligand-dependent T cell activation: requirement of B7-CD28 signaling through CD40. Science 1996; 273: 1862.
46. McLellan AD, Sorg RV, Williams LA, Hart DNJ. Human dendritic cells activate T lymphocytes via a CD40: CD40 ligand-dependent pathway. Eur J Immunol 1996; 26: 1204.
47. Caux C, Massacrier C, Vanbervliet B, et al. Activation of human dendritic cells through CD40 cross-linking. J Exp Med 1994; 180: 1263.
48. Ludewig B, Graf D, Gelderblom HR, Becker Y, Kroczek RA, Pauli G. Spontaneous apoptosis of dendritic cells is efficiently inhibited by TRAP (CD40-ligand) and TNF-α, but strongly enhanced by interleukin-10. Eur J Immunol 1995; 25: 1943.
49. Pinchuk LM, Klaus SJ, Magaletti DM, Pinchuk GV, Norsen JP, Clark EA. Functional CD40 ligand expressed by human blood dendritic cells is up-regulated by CD40 ligation. J Immunol 1996; 157: 4363.
50. Grewal IS, Xu J, Flavell RA. Impairment of antigen-specific T-cell priming in mice lacking CD40 ligand. Nature 1995; 378: 617.
51. + T cells. Eur J Immunol 1995; 25: 2285.
52. Koch F, Stanzl U, Jennewein P, et al. High level IL-12 production by murine dendritic cells: upregulation via MHC class II and CD40 molecules and downregulation by IL-4 and IL-10. J Exp. Med 1996; 184: 741.
53. Cella M, Scheidegger D, Palmer-Lehmann K, Lane P, Lanzavecchia A, Alber G. Ligation of CD40 on dendritic cells triggers production of high levels of interleukin-12 and enhances T cell stimulatory capacity: T-T help via APC activation. J Exp Med 1996; 184: 747.
54. Larsen CP, Alexander DZ, Hollenbaugh D, et al. CD40-gp39 interactions play a critical role during allograft rejection: suppression of allograft rejection by blockade of the CD40-gp39 pathway. Transplantation 1996; 61: 4.
55. + T cell-mediated alloreactivity by inhibiting mature donor T cell expansion and function after bone marrow transplantation. J Immunol 1997; 158: 29.
56. Buhlmann JE, Foy TM, Aruffo A, et al. In the absence of a CD40 signal, B cells are tolerogenic. Immunity 1995; 2: 645.
57. Larsen CP, Elwood ET, Alexander DZ, et al. Long-term acceptance of skin and cardiac allografts after blocking CD40 and CD28 pathways. Nature 1996; 381: 434.
58. Parker DC, Greiner DL, Phillips NE, et al. Survival of mouse pancreatic islet allografts in recipients treated with allogeneic small lymphocytes and antibody to CD40 ligand. Proc Natl Acad Sci USA 1995; 92: 9560.
59. Hancock WW, Sayegh MH, Zheng X-G, Peach R, Linsley PS, Turka LA. Costimulatory function and expression of CD40 ligand, CD80, and CD86 in vascularized murine cardiac allograft rejection. Proc Natl Acad Sci USA 1996; 93: 13967.
60. Yin D, Fathman CG. Induction of tolerance to heart allografts in high responder rats by combining anti-CD4 with CTLA4Ig. J Immunol 1995; 155: 1655.
61. Chirmule N, McCloskey TW, Hu R, Kalyanaraman VS, Pahwa S. HIV gp120 inhibits T cell activation by interfering with expression of costimulatory molecules CD40 ligand and CD80 (B71). J Immunol 1995; 155: 917.